Granulocytapheresis against severe alcoholic hepatitis
Not Applicable
Suspended
- Conditions
- severe alcoholic hepatitisalcoholic hepatitis
- Registration Number
- JPRN-jRCTs032180221
- Lead Sponsor
- akamoto Nobuhiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
the patients who meet the diagnostic criteria of severe alcoholic hepatitis
the patients who are able to keep vascular access
the patients who obtained their written informed consent
Exclusion Criteria
the patients whose granulocyte count are below 2000
the patients who complicated with severe infection, severe heart disease, uncontrolled cancer, and end-stage liver cirrhosis
the patients who are pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome at 90 days after the initiation of granulocytapheresis
- Secondary Outcome Measures
Name Time Method the rate of normalization of white blood cells count <br>the rate of improvement of liver function <br>Safety